Why researchers use zebrafish to study a cancer-linked inflammation pathway

byMemorial Sloan Kettering Cancer CenterGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2022.111974In science, how you ask a question is often as important as wh

Updated on: January 08,2024

Why researchers use zebrafish to study a cancer-linked inflammation pathway

byMemorial Sloan Kettering Cancer CenterGraphical Abstract. Credit:Cell Reports(2023). DOI: 10.1016/j.celrep.2022.111974In science, how you ask a question is often as important as wh

Updated on:January 08,2024

What is the breast cancer risk calculator recommended by Olivia Munn?

by Carla K. JohnsonOlivia Munn arrives at the Governors Awards on Tuesday, Jan. 9, 2024, at the Dolby Ballroom in Los Angeles. When Munn revealed in March 2024 that she was diagnosed with breast cance

Updated on: March 20,2024

What is the breast cancer risk calculator recommended by Olivia Munn?

by Carla K. JohnsonOlivia Munn arrives at the Governors Awards on Tuesday, Jan. 9, 2024, at the Dolby Ballroom in Los Angeles. When Munn revealed in March 2024 that she was diagnosed with breast cance

Updated on:March 20,2024

The power of machine learning in prostate cancer imaging

by Lisette Hilton,University of Miami(From left) Isaac R. L. Xu; Derek J. Van Booven; and Himanshu Arora, Ph.D. Credit: University of MiamiResearchers at Sylvester Comprehensive Cancer Center an

Updated on: December 25,2023

The power of machine learning in prostate cancer imaging

by Lisette Hilton,University of Miami(From left) Isaac R. L. Xu; Derek J. Van Booven; and Himanshu Arora, Ph.D. Credit: University of MiamiResearchers at Sylvester Comprehensive Cancer Center an

Updated on:December 25,2023

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on: September 27,2024

Trial demonstrates firmonertinib is a potential therapy for patients with NSCLC with EGFR PACC mutations

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe tyrosine kinase inhibitor firmonertinib showed promising efficacy in patients with non-small cell lung can

Updated on:September 27,2024

Understanding how the perception of risks and benefits influences cancer clinical trial withdrawal outcomes

byUniversity of Pennsylvania School of NursingCredit: Unsplash/CC0 Public DomainWhile people with cancer have options to participate in cancer clinical trials (CCTs), it can be challenging when

Updated on: December 28,2023

Understanding how the perception of risks and benefits influences cancer clinical trial withdrawal outcomes

byUniversity of Pennsylvania School of NursingCredit: Unsplash/CC0 Public DomainWhile people with cancer have options to participate in cancer clinical trials (CCTs), it can be challenging when

Updated on:December 28,2023

Researchers discover critical process for how breast cancer spreads in bones

by Brandi Wampler,University of Notre DameScientist Laurie Littlepage works with graduate student Ricardo Romero Moreno in her lab at the Harper Cancer Research Institute. Credit: Barbara Johnst

Updated on: June 19,2024

Researchers discover critical process for how breast cancer spreads in bones

by Brandi Wampler,University of Notre DameScientist Laurie Littlepage works with graduate student Ricardo Romero Moreno in her lab at the Harper Cancer Research Institute. Credit: Barbara Johnst

Updated on:June 19,2024

Inside the new colorectal cancer screening guidelines for average-risk patients

by Mayo Clinic News NetworkCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0The American College of Physicians has produced a guidance statement for colorectal cancer s

Updated on: April 20,2024

Inside the new colorectal cancer screening guidelines for average-risk patients

by Mayo Clinic News NetworkCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0The American College of Physicians has produced a guidance statement for colorectal cancer s

Updated on:April 20,2024

Tracing cancer back to birth uncovers promising biomarkers for prevention, targeted treatment of childhood leukemia

byMurdoch Children's Research InstituteDiscovery, validation and functional analysis of VTRNA2-1 methylation in association with pediatric pre-B ALL development. Credit:Molecular Cance

Updated on: November 11,2024

Tracing cancer back to birth uncovers promising biomarkers for prevention, targeted treatment of childhood leukemia

byMurdoch Children's Research InstituteDiscovery, validation and functional analysis of VTRNA2-1 methylation in association with pediatric pre-B ALL development. Credit:Molecular Cance

Updated on:November 11,2024

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on: December 18,2023

Avelumab plus axitinib significantly improve progression-free survival in untreated renal cell carcinoma

byEuropean Society for Medical OncologyCredit: CC0 Public DomainA combination of the immune checkpoint blocker, avelumab, plus the tyrosine kinase inhibitor (TKI), axitinib, significantly improv

Updated on:December 18,2023

Genetic discovery could improve treatment of colorectal cancer

by Rémi Carlier,Ecole Polytechnique Federale de LausannePOU5F1B differs from OCT4. a Representative immunofluorescence–confocal microscopy of POU5F1B-HA overexpressing SW480 cells, with DAPI in

Updated on: December 25,2023

Genetic discovery could improve treatment of colorectal cancer

by Rémi Carlier,Ecole Polytechnique Federale de LausannePOU5F1B differs from OCT4. a Representative immunofluorescence–confocal microscopy of POU5F1B-HA overexpressing SW480 cells, with DAPI in

Updated on:December 25,2023

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi

Updated on: December 28,2023

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi

Updated on:December 28,2023

Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

byUniversity of OxfordSpleen sections from mito-QC mice immunized with SRBC and analyzed on day 12. Scale bar, 50 μm. Representative of three independent experiments. Credit:Nature Immunol

Updated on: January 10,2024

Mitochondrial protein synthesis identified as a potential therapeutic target in lymphoma

byUniversity of OxfordSpleen sections from mito-QC mice immunized with SRBC and analyzed on day 12. Scale bar, 50 μm. Representative of three independent experiments. Credit:Nature Immunol

Updated on:January 10,2024